Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction
Tetsuro Noguchi, Ute Hamann(German Cancer Research Center), Anna Allavena(University of Turin), Annika Lindblom(Karolinska University Hospital), Trinidad Caldés(Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), E.J. Meijers-Heijboer, Helena Jernström(Lund University), Thomas van Overeem Hansen(University of Copenhagen), Kathleen Claes(Statistics Belgium), Eitan Friedman(University of Pennsylvania), Christoph Engel(University Hospital Leipzig), Siranoush Manoukian(Fondazione IRCCS Istituto Nazionale dei Tumori), Cora M. Aalfs(University of Amsterdam), Marco Montagna(Azienda Ospedale - Università Padova), Bella Kaufman(NYU Langone Health), Susan J. Ramus(Cancer Institute of New South Wales), Javier Benı́tez(Spanish National Cancer Research Centre), Sabine Preisler‐Adams, Laurence Venat‐Bouvet(Hôpital Universitaire Dupuytren), Jacques Simard(Université Laval), Norbert Arnold(Christian-Albrechts-Universität zu Kiel), Susan L. Neuhausen(City of Hope), Mary Beth Terry(Columbia University Irving Medical Center), Susan M. Domchek(University City Science Center), Alexander Miron(Harvard University), Ines Schönbuchner(University Hospital Regensburg), Conxi Lázaro(Institut d'Investigació Biomédica de Bellvitge), Claudine Isaacs(Georgetown University), Michal Zikán(Charles University), Saundra S. Buys(University of Utah), Roni Milgrom(Sheba Medical Center), Rob B. van der Luijt(Institute for Quality and Efficiency in Health Care), Xianshu Wang(Kunming University of Science and Technology), Uffe Birk Jensen(Aarhus University Hospital), Jonathan Beesley(The University of Melbourne), Trevor Cole(Birmingham Women's Hospital), Lisa Walker(Oxford University Hospitals NHS Trust), Mary Porteous(University of Edinburgh), Kristiina Aittomäki(University of Helsinki), Lesley McGuffog(University of Cambridge), Johanna Rantala(Karolinska University Hospital), Alfons Meindl(Helmholtz Zentrum München), Laurence Faivre(Centre Georges François Leclerc), Agnès Hardouin(University Medical Center Utrecht), Maria A. Caligo(Azienda Ospedaliera Universitaria Pisana), Alessandra Viel(Centro di Riferimento Oncologico), Jackie Cook(Sheffield Children's Hospital)
Cited by 19
Related Papers
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Mortality Results from a Randomized Prostate-Cancer Screening Trial
|New England Journal of Medicine|2009|2.9k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation
|Journal of Clinical Oncology|2014|1.7k